Homepage

In addition, active exchange of good practices and standards is sought with other European cohorts studying the morbidity and mortality of HIV/AIDS both in adults and children. This way, a powerful platform is realized for communication between HIV/AIDS cohort studies.
This increased coordination will lead to new coordinated data and knowledge on transmission, prevalence and factors facilitating the emergence and spread of drug resistant HIV in Europe, providing the pharmaceutical industry, scientific community and public health authorities with valuable new input for the development of new drugs, new treatment recommendations, intervention programs and prophylactic guidelines necessary to effectively confront the global emergency caused by HIV.